The revitalisation of GSK's blood cancer therapy Blenrep has continued with a second regulatory approval, in Japan, as a ...

A federal district court ruled in favor of the Health Resources and Services Administration, but raised questions about ...

For initial treatment of symptomatic pulmonary sarcoidosis, methotrexate appeared to work as well as prednisone over 24 weeks ...

In patients with venous thromboembolism (VTE) who are candidates for oral anticoagulation, apixaban results in fewer ...

Although the Trump administration's healthcare policies pose risks for Bristol-Myers Squibb, the chaos opens a contrarian door for BMY stock.

Bristol-Myers Squibb Co. prevailed against investor allegations it misled them about a payout tied to Food and Drug ...

Talent platform Eightfold rolled out two transformative agentic AI tools at its recent summit: AI Interviewer Agent and ...

Bristol Myers Squibb is calling on the world to chip in more for drug costs to support U.S. research and development. CEO ...

Treatment-resistant schizophrenia is a disabling illness, affecting approximately 8 million people worldwide with profound ...

Shares of Bristol Myers Squibb Co. rose 3.83% to $45.81 Thursday, on what proved to be an all-around great trading session ...

Treatment of optic neuritis with corticosteroids, findings from the Optic Neuritis Treatment Trial and the validity of ...

First-line treatment with nivolumab (Opdivo) and ipilimumab (Yervoy) significantly improved survival compared with lenvatinib ...